DRESS REACTION TO ANAKINRA IN A PATIENT WITH SEVERE SYSTEMIC JUVENILE ARTHRITIS (SJIA)

被引:0
|
作者
Zhang, M.
Eddens, T.
Van Meerbeke, S.
Coffey, K.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
M007
引用
收藏
页码:S59 / S60
页数:2
相关论文
共 50 条
  • [41] Tocilizumab therapy improves abnormal mitochondrial function in patients with systemic juvenile idiopathic arthritis (sJIA)
    Mima, Toru
    Aoki, Chieko
    Adachi, Yasuo
    Suguno, Hidehiko
    Lee, Hooiming
    Yoshio-Hoshino, Naoko
    Imagawa, Tomoyuki
    Mori, Masaaki
    Tomiita, Minako
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Takei, Syuji
    Aihara, Yukoh
    Yokota, Shumpei
    Matsubara, Kenichi
    Nishimoto, Norihiro
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S497 - S498
  • [42] EFFICACY AND SAFETY OF ANAKINRA IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS - DATA OF THE BIKER REGISTRY
    Klein, Ariane
    Atemnkeng, Veronika Ntam
    Dressler, Frank
    Foeldvari, Ivan
    Kuester, Rolf Michael
    Hospach, Toni
    Ganser, Gerd
    Minden, Kirsten
    Foell, Dirk
    Weller-Heinemann, Frank
    Kuemmerle-Deschner, Jasmin
    Huegle, Boris
    Rietschel, Christoph
    Lilienthal, Eggert
    Horneff, Gerd
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 976 - 976
  • [43] THE IMPACT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) ON A CAREGIVER'S PRODUCTIVITY AND THE CHILD'S SCHOOLING
    Shenoi, S.
    Horneff, G.
    Cidon, M.
    Ramanan, A.
    Kimura, Y.
    Quartier, P.
    Foeldvari, I
    Zeft, A.
    Lomax, K.
    Gregson, J.
    Mckenna, S. J.
    Abma, T.
    Campbell, S.
    Weiss, J.
    Marinsek, N.
    Patel, D.
    Wulffraat, N.
    VALUE IN HEALTH, 2017, 20 (09) : A561 - A561
  • [44] A SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND SAFETY OF PHARMACOLOGICAL TREATMENTS IN PATIENTS WITH SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA)
    Kuemmerle-Deschner, Jasmin
    Thakur, Lalit
    George, Aneesh
    Hur, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 994 - 995
  • [45] Differential expression of immune parameters in systemic juvenile idiopathic arthritis (SJIA) flare and quiescence.
    Nguyen, Khoo
    Macaubas, Claudia
    Deshpande, Chetan
    Lee, Tzielan
    Sandborg, Christy
    Mellins, Elizabeth
    CLINICAL IMMUNOLOGY, 2006, 119 : S72 - S72
  • [46] Risk Score of Macrophage Activation Syndrome (MAS) in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA)
    Carbogno, Simone
    Marafon, Denise Pires
    Marucci, Giulia
    Sacco, Emanuela
    Pardeo, Manuela
    Alsaleem, Alhanouf
    Fingerhutova, Sarka
    Demir, Ferhat
    Cekada, Nastasia
    Kostik, Mikhail
    Kessel, Christoph
    Vougiouka, Olga
    Gagro, Alenka
    Tibaldi, Jessica
    Minoia, Francesca
    Maccora, Ilaria
    Schneider, Rayfel
    Dolezalova, Pavla
    Sozeri, Betul
    Jelusic, Marija
    Insalaco, Antonella
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [47] Anakinra for Myocarditis in Juvenile Idiopathic Arthritis
    Movva, Rajesh
    Brown, Suzanne B.
    Morris, D. Lynn
    Figueredo, Vincent M.
    TEXAS HEART INSTITUTE JOURNAL, 2013, 40 (05): : 623 - 625
  • [48] Validation of Patient-reported Outcomes (PRO) Lung Questionnaires for Systemic Juvenile Idiopathic Arthritis (SJIA) Patients at Risk for Lung Disease
    Kim Nguyen
    Towe, Christopher
    Yasin, Shima
    Grom, Alexei
    Brunner, Hermine I.
    Schulert, Grant
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [49] The use of anakinra in juvenile arthritis.
    Reiff A.
    Current Rheumatology Reports, 2005, 7 (6) : 434 - 440
  • [50] Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review
    Aguiar, Cassyanne L.
    Pan, Nancy
    Adams, Alexa
    Barinstein, Laura
    Lehman, Thomas J.
    CLINICAL RHEUMATOLOGY, 2015, 34 (10) : 1821 - 1824